US approves first drug treatment for sleep apnea

US approves first drug treatment for sleep apnea
US approves first drug treatment for sleep apnea

Good news for the sleep apnea patients: the US has approved the first-ever drug treatment for them.

According to Science Alert, US regulators on Friday, December 20, 2024, approved Zepbound from drugmaker Eli Lilly for the treatment of moderate to severe apnea in obese patients.

US Food and Drugs Administration official Sally Seymour, while announcing the approval of Zepbound, stated, “Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea." This is a major step forward for patients with obstructive sleep apnea.”

FDA said in a statement, “Zepbound works by activating receptors of hormones secreted from the intestine… to reduce appetite and food intake. By reducing body weight, studies show that Zepbound also improves OSA.”

The authority said that they have approved the treatment after it showed promising results in the two clinical trials.

Patrik Jonsson, a senior executive at Eli Lilly, said in a statement, “Nearly half of clinical trial patients saw such improvements that they no longer had symptoms associated with OSA, marking a critical step forward in reducing the burden of this disease and its interconnected health challenges.”

As per the American Academy of Sleep Medicine, around 30 million adults in the US suffer from sleep apnea.

Related
Read more : Health

Healthy plant-based diet may reduce inflammatory bowel disease risk, study

Healthy plant-based diet may reduce inflammatory bowel disease risk, study
Researchers find found an inverse link between a healthy PDI and ulcerative colitis risk ( hazard ratio [HR], 0.92)

Premenstrual disorders associated with increased risk of cardiac diseases

Premenstrual disorders associated with increased risk of cardiac diseases
Results indicated that women with premenstrual symptoms were at a 10% increased risk of developing a cardiac disorder

Researchers create advanced AI tool to screen for Diabetic retinopathy

Researchers create advanced AI tool to screen for Diabetic retinopathy
Researchers stated that the AI efficiently distinguished Diabetic retinopathy from other eye-related diseases

Diet significantly influences constipation risk, study

Diet significantly influences constipation risk, study
Results indicated that a western diet with red and processed meats, refined grains raised the risk of chronic constipation by 22%

FDA approves Kerendia for cardiac failure with LVEF ≥40 percent

FDA approves Kerendia for cardiac failure with LVEF ≥40 percent
Kerendia, a nonsteroidal mineralocorticoid receptor antagonist that inhibits overactivation of mineralocorticoid receptors

Measles outbreak: Alberta exceeds case counts reported across US

Measles outbreak: Alberta exceeds case counts reported across US
Alberta reports 1,314 cases since March, surpassing the United States in confirmed measles cases

Cancer patients given new hope as NHS chief declares major progress

Cancer patients given new hope as NHS chief declares major progress
A senior NHS official has shared a message of hope for those facing a cancer diagnosis

Top home remedies to beat dandruff in 2025

Top home remedies to beat dandruff in 2025
Discover a few effective ways to naturally reduce dandruff at home